Ground glass appearance is a nonspecific finding that can see in diseases such as chronic interstitial disease, acute alveolar disease or infection; however, it is most commonly encountered in COVID-19 pulmonary involvement today. The mammalian target of rapamycin (mTOR) plays a regulatory role in cell proliferation and growth. Everolimus is an allosteric mTOR inhibitor used in ER+ breast cancers and inhibits the mTOR functional complex. Here, we present a case of interstitial pneumonia due to everolimus, which can be confused with COVID-19 pneumonia due to its ground-glass appearance during the pandemic period.
Everolimus mTOR ground glass interstitial pneumonia Covid-19 breast cancer
Birincil Dil | İngilizce |
---|---|
Konular | İç Hastalıkları |
Bölüm | Case Reports |
Yazarlar | |
Yayımlanma Tarihi | 1 Nisan 2022 |
Gönderilme Tarihi | 24 Şubat 2022 |
Kabul Tarihi | 9 Mart 2022 |
Yayımlandığı Sayı | Yıl 2022 Cilt: 4 - Supplement 1 |